Do you offer OEM or ODM services?

Yes, we provide both OEM and ODM services for our veterinary products.

What payment methods are accepted?

We accept LC, T/T, D/P, PayPal, Western Union, and small-amount payments.

Where is the company located?

Our factory is located at 9 Yugang Road, Zhengzhou Airport Economic Comprehensive Experimental Zone, Zhengzhou.

Macrolide Antiparasitic Drugs Ivermectin Tablets for Veterinary Use

Name: Macrolide Antiparasitic Drugs Ivermectin Tablets for Veterinary Use
Brand: Henan Muxiang Biological Co., Ltd.
SKU: 1975959132

Henan, ChinaHenan Muxiang Biological Co., Ltd.

US$120.00

1-9 Boxes

US$110.00

10-99 Boxes

US$100.00

100+ Boxes

Sample price:US$120.00/box.Request sample

Product profile

Customization

Available

Varieties

General Disease Prevention Medicine

Component

Chemical Synthetic Drugs

Model NO.

TABLETS

Type

The First Class

Pharmacodynamic Influential Factors

Combined Medication

Storage Method

Light Proof

Transport Package

Carton

Specification

100pieces/Bottle

Trademark

Moosun

Origin

China

HS Code

3004909099

Production Capacity

50000 Bottles/Month

Key features

Veterinary Parasite Control: Effective against nematodes, mites, and parasitic insects in sheep and pigs.

Precise Dosage Guidelines: 0.27 tablet per 10kg for sheep; 0.4 tablet per 10kg for swine.

Standard Packaging: 100 tablets per bottle, 60 bottles per box for convenient distribution.

Established Manufacturer: Factory established in 2004 with 360 employees and 20 R&D engineers.

Global Export Capability: Exports to North America, Europe, Southeast Asia, Africa, and more.

Flexible OEM/ODM: OEM and ODM services available for customized product needs.

Multiple Payment Options: Accepts LC, T/T, D/P, PayPal, Western Union, and small payments.

Fast Lead Time: Average lead time of one month for both peak and off-season orders.

Company profile

Henan Muxiang Biological Co., Ltd.

Henan, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2016-02-01 CertifiedNearest Port: Shanghai Port, Qingdao PortAverage Response Time: ≤11.88h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryHenan Muxiang Biological Co., Ltd. is a China-based limited-company factory established in 2004, with 360 employees and operations in veterinary pharmaceuticals and animal-health products. The supplier reports seven pharmaceutical production lines, eight vaccine production lines, first-class production and inspection equipment, GMP management, ISO9001:2015 certification, and ISO/CNAS laboratory certification. Its R&D resources include more than 40 core personnel, over 30 of whom hold doctoral or master's degrees, while 21–30 quality-control staff are reported. The company exports to multiple global regions, has self-operated import and export rights, and states a one-month order-fulfillment period in both peak and off-peak seasons. Evidence supports capabilities in certification, innovation, production, and international operations. However, the provided information does not sufficiently establish after-sales service performance, financial credibility, customization execution, or specific customer cases.

Supplier typeThe supplier is identified as a limited company and a factory in the manufacturing industry, with its operating location in Henan, China. This indicates a direct manufacturing entity rather than only a trading or intermediary business.

CertificationsThe supplier reports a systematic GMP management system, ISO/CNAS laboratory international certification, and an ISO9001:2015 certificate. These stated certifications and quality systems provide explicit evidence of formal quality-management capability.

R&D capabilityThe supplier reports more than 40 core R&D personnel, including over 30 doctors or master's degree graduates, 20 years of preparation-technology experience among R&D engineers, and advanced R&D platforms such as a National Enterprise Technology Center, National Postdoctoral Research Station, and Academician Workstation. It also reports improving herbal active-ingredient extraction by more than 30% versus a traditional process, supporting a strong stated innovation profile.

Production capacityThe supplier reports seven pharmaceutical production lines and eight vaccine production lines, first-class production and inspection equipment, six production lines in a separate operational data field, and one-month order fulfillment in both peak and off-peak seasons. Although the line-count figures are not fully consistent across the slices, the evidence clearly supports substantial pharmaceutical and vaccine manufacturing capability.